跳至主要内容
临床试验/NCT06610786
NCT06610786尚未招募不适用

The Use of FCSB in Medium-complex RRD - a Safety and Efficacy Evaluation

Eye & ENT Hospital of Fudan University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
100
试验地点
1
主要终点
anatomic success rate

研究概览

简要总结

The objective of the study is to evaluate:

  1. Safety and efficacy of a novel foldable capsular scleral buckle (FCSB) in scleral buckling for primary rhegmatogenous retinal detachment (RRD) of medium complexity.
  2. Comparison between FCSB and pars plana vitrectomy in therapeutic effects and complications in the treatment of primary RRD of medium complexity.

详细描述

Pars plana vitrectomy (PPV) and scleral buckling (SB) are major choices in treating rhegmatogenous retinal detachment (RRD) of medium complexity. PPV is more prevailed since it improved internal search for breaks and elimination of vitreous traction. SB has unmatched advantages over PPV such as earlier rehabilitation, free from prolonged positioning, less complicated cataract or glaucoma. The novel foldable capsular scleral buckle (FCSB) can create a big bulge by pressing on the sclera and seal the break in bullous RRD without scleral drainage. In the study, differences of anatomic and functional results between PPV and FCSB in treating primary RRD of medium complexity are evaluated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • One or more retinal holes which cannot be treated sufficiently with a single silicon sponge or silicone band (e.g. large holes, multiple holes, multiple holes of varying anterior-posterior localisation, massive traction)
  • Exclusion Criteria
  • simple rhegmatogenous retinal detachment which can be treated with a single silicon sponge or silicone band (e.g. single holes, no traction, limit retinal detachment)
  • Complicated RRD, including macular hole within the arcade, PVR C or D, severe cataract, severe vitreous hemorrhage, unclear macular hole,
  • Combined with other eye diseases that affect vision prognosis.
  • History of other eye surgeries including cataract surgery.
  • Presence of systemic diseases that may affect postoperative observation and follow-up.

排除标准

  • 未提供

结局指标

主要结局

anatomic success rate

时间窗: From enrollment to the end of treatment at 6 months

The success rate of retinal reattachment

metamorphopsia

时间窗: From enrollment to the end of treatment at 6 months

metamorphopsia is measured by M chart

Visual Results

时间窗: From enrollment to the end of treatment at 6 months

Best-Corrected Visual Acuity, and is measured by Snellen Chart, EDTRS Chart and charts designed for people with low vision

次要结局

  • The number of surgeries that achieved successful final retinal reattachment(From enrollment to the end of treatment at 6 months)
  • Surgical Complications(From enrollment to the end of treatment at 6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验